ArticlePharmacogenomics and personalized medicine2023

PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer.

Wei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.